2026 SPS Denver | Tarlatamab and Tebentafusp Bispecifics: Clinical and Practical Considerations in the Solid Tumors Setting
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 23, 2026
- Last Review
- May 23, 2026
- Expires
- May 23, 2029
Objectives
NA
Target Audience
Pharmacists
Faculty & Disclosure
Faculty
Benjamin Yoder, PharmD, BCOP
Disclosure
NA
Accreditation
NA
